147 related articles for article (PubMed ID: 35191489)
1. TSAFinder: exhaustive tumor-specific antigen detection with RNAseq.
Sharpnack MF; Johnson TS; Chalkley R; Han Z; Carbone D; Huang K; He K
Bioinformatics; 2022 Apr; 38(9):2422-2427. PubMed ID: 35191489
[TBL] [Abstract][Full Text] [Related]
2. Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.
Qi YA; Maity TK; Cultraro CM; Misra V; Zhang X; Ade C; Gao S; Milewski D; Nguyen KD; Ebrahimabadi MH; Hanada KI; Khan J; Sahinalp C; Yang JC; Guha U
Mol Cell Proteomics; 2021; 20():100136. PubMed ID: 34391887
[TBL] [Abstract][Full Text] [Related]
3. Genome-scale search of tumor-specific antigens by collective analysis of mutations, expressions and T-cell recognition.
Jia J; Cui J; Liu X; Han J; Yang S; Wei Y; Chen Y
Mol Immunol; 2009 May; 46(8-9):1824-9. PubMed ID: 19243822
[TBL] [Abstract][Full Text] [Related]
4. NeoFuse: predicting fusion neoantigens from RNA sequencing data.
Fotakis G; Rieder D; Haider M; Trajanoski Z; Finotello F
Bioinformatics; 2020 Apr; 36(7):2260-2261. PubMed ID: 31755900
[TBL] [Abstract][Full Text] [Related]
5. nextNEOpi: a comprehensive pipeline for computational neoantigen prediction.
Rieder D; Fotakis G; Ausserhofer M; René G; Paster W; Trajanoski Z; Finotello F
Bioinformatics; 2022 Jan; 38(4):1131-1132. PubMed ID: 34788790
[TBL] [Abstract][Full Text] [Related]
6. CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens.
Bais P; Namburi S; Gatti DM; Zhang X; Chuang JH
Bioinformatics; 2017 Oct; 33(19):3110-3112. PubMed ID: 28605406
[TBL] [Abstract][Full Text] [Related]
7. MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.
Cai W; Zhou D; Wu W; Tan WL; Wang J; Zhou C; Lou Y
BMC Genomics; 2018 Aug; 19(1):582. PubMed ID: 30075702
[TBL] [Abstract][Full Text] [Related]
8. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
[TBL] [Abstract][Full Text] [Related]
9. ScanNeo: identifying indel-derived neoantigens using RNA-Seq data.
Wang TY; Wang L; Alam SK; Hoeppner LH; Yang R
Bioinformatics; 2019 Oct; 35(20):4159-4161. PubMed ID: 30887025
[TBL] [Abstract][Full Text] [Related]
10. NeoSplice: a bioinformatics method for prediction of splice variant neoantigens.
Chai S; Smith CC; Kochar TK; Hunsucker SA; Beck W; Olsen KS; Vensko S; Glish GL; Armistead PM; Prins JF; Vincent BG
Bioinform Adv; 2022; 2(1):vbac032. PubMed ID: 35669345
[TBL] [Abstract][Full Text] [Related]
11. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
[TBL] [Abstract][Full Text] [Related]
12. Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes.
Ehx G; Larouche JD; Durette C; Laverdure JP; Hesnard L; Vincent K; Hardy MP; Thériault C; Rulleau C; Lanoix J; Bonneil E; Feghaly A; Apavaloaei A; Noronha N; Laumont CM; Delisle JS; Vago L; Hébert J; Sauvageau G; Lemieux S; Thibault P; Perreault C
Immunity; 2021 Apr; 54(4):737-752.e10. PubMed ID: 33740418
[TBL] [Abstract][Full Text] [Related]
13. PSSMHCpan: a novel PSSM-based software for predicting class I peptide-HLA binding affinity.
Liu G; Li D; Li Z; Qiu S; Li W; Chao CC; Yang N; Li H; Cheng Z; Song X; Cheng L; Zhang X; Wang J; Yang H; Ma K; Hou Y; Li B
Gigascience; 2017 May; 6(5):1-11. PubMed ID: 28327987
[TBL] [Abstract][Full Text] [Related]
14. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
[TBL] [Abstract][Full Text] [Related]
15. LENS: Landscape of Effective Neoantigens Software.
Vensko SP; Olsen K; Bortone D; Smith CC; Chai S; Beckabir W; Fini M; Jadi O; Rubinsteyn A; Vincent BG
Bioinformatics; 2023 May; 39(6):. PubMed ID: 37184881
[TBL] [Abstract][Full Text] [Related]
16. POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction.
Meng Q; Wu Y; Sui X; Meng J; Wang T; Lin Y; Wang Z; Zhou X; Qi Y; Du J; Gao Y
Front Immunol; 2020; 11():02193. PubMed ID: 33133063
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA as a source of neoantigens for cancer vaccines.
Ren Y; Manoharan T; Liu B; Cheng CZM; En Siew B; Cheong WK; Lee KY; Tan IJ; Lieske B; Tan KK; Chia G
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38508656
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer immunopeptidomes contain numerous shared tumor antigens.
Kina E; Laverdure JP; Durette C; Lanoix J; Courcelles M; Zhao Q; Apavaloaei A; Larouche JD; Hardy MP; Vincent K; Gendron P; Hesnard L; Thériault C; Ruiz Cuevas MV; Ehx G; Thibault P; Perreault C
J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 37906288
[TBL] [Abstract][Full Text] [Related]
19. INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery.
Zhang J; Mardis ER; Maher CA
Bioinformatics; 2017 Feb; 33(4):555-557. PubMed ID: 27797777
[TBL] [Abstract][Full Text] [Related]
20. Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse.
Rijensky NM; Blondheim Shraga NR; Barnea E; Peled N; Rosenbaum E; Popovtzer A; Stemmer SM; Livoff A; Shlapobersky M; Moskovits N; Perry D; Rubin E; Haviv I; Admon A
Mol Cell Proteomics; 2020 Aug; 19(8):1360-1374. PubMed ID: 32451349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
